Aurinia Pharmaceuticals Inc (AUPH) earnings · P/E 7.2, $1.03B cap
These earnings events as JSON? API free 100/dayAurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
This AUPH earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AUPH revenue for 2026-06-30 was $83.2M. Net income was $37.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. AUPH currently screens at market cap $1.03B and trailing P/E 7.2.
When the next AUPH 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 7.1% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full AUPH research stays on the stock page; the tape stays on the quote page.
AUPH earnings FAQ
What are AUPH's latest revenue and net income?
Latest cached Aurinia Pharmaceuticals Inc (AUPH) revenue for Jun 30, 2026 was $83.2M. Net income was $37.4M. Statements: https://lician.com/financials/auph
What is AUPH's latest diluted EPS?
Latest cached Aurinia Pharmaceuticals Inc (AUPH) diluted EPS for Jun 30, 2026 was $0.28.
What period does the latest AUPH earnings print cover?
The latest cached Aurinia Pharmaceuticals Inc (AUPH) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did AUPH revenue change from the prior cached period?
Cached Aurinia Pharmaceuticals Inc (AUPH) revenue was up 7.1% from $77.7M (Mar 31, 2026) to $83.2M (Jun 30, 2026). Statements: https://lician.com/financials/auph
What is AUPH's P/E ratio?
Aurinia Pharmaceuticals Inc (AUPH) trailing P/E is 7.21 on the latest cached fundamentals snapshot.
Where are AUPH earnings listed?
Cached earnings facts for Aurinia Pharmaceuticals Inc (AUPH) are listed at https://lician.com/earnings/auph. Statements: https://lician.com/financials/auph
Not investment advice.